United Kingdom · 
Who invested in GenoMe Diagnostics?
GenoMe Diagnostics's investors include Innovate UK.
United Kingdom · Seed startup
Who invested in GenoMe Diagnostics
Funding summaryUpdated 26 Oct 2026
$1.7Mraised across 1 round since 2023, from 1 source
- Latest round
- Seed, $1.7MMar 2023
- Investors
- 1
The rounds
- Mar 2023
Funding filed with regulators
GenoMe Diagnostics filed 4 raises, $1.5M in all. Filings say how much was sold and to how many investors; they never name the investors.
- May 2023$414KUK share allotment
- Apr 2023$369KUK share allotment
- Apr 2023$574KUK share allotment
- Mar 2023$153KUK share allotment
Founders and team
From GenoMe Diagnostics's own website: 4 on the team.
- Dr Shannon BeattieChief Executive Officer
- Professor Paul MullanChief Scientific Officer
- Dr Charlotte McBrienLaboratory Manager
- Dr Mark Street DochertyExecutive Chair
AdvisersDr David CorrDr James BeirneDr Laura FeeneyMr Jim Thurlow
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about GenoMe Diagnostics
How much has GenoMe Diagnostics raised?
GenoMe Diagnostics has raised $1.7M across 1 round since 2023.
When did GenoMe Diagnostics last raise?
GenoMe Diagnostics's most recent round was a Seed of $1.7M in Mar 2023.
What was GenoMe Diagnostics's biggest round?
Its most recent round, $1.7M in Mar 2023, is also its largest on record.
Who backed GenoMe Diagnostics first?
GenoMe Diagnostics's first round on record, in Mar 2023, was backed by Innovate UK.
What stage is GenoMe Diagnostics at?
GenoMe Diagnostics's latest named round is a Seed, in Mar 2023.
Where is GenoMe Diagnostics based?
GenoMe Diagnostics is based in the United Kingdom.
Companies like GenoMe Diagnostics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.